TY  - CONF
AU  - Arias De la Rosa, I.
AU  - Ruiz-Ponce, M.
AU  - Lopez, L. Cuesta
AU  - Gahete, M. D.
AU  - Herman-Sanchez, N.
AU  - Lucendo-Villarin, A.
AU  - Navarro-Sanchez, P.
AU  - Abalos-Aguilera, M. C.
AU  - Perez-Sanchez, C.
AU  - Castro, R. Ortega
AU  - Gutierrez, J. Calvo
AU  - Lopez-Pedrera, C.
AU  - Contreras, A. Escudero
AU  - Estevez, E. Collantes
AU  - Puerto, N. Barbarroja
PY  - 2022
DO  - 10.1136/annrheumdis-2022-eular.3820
SN  - 0003-4967
UR  - http://hdl.handle.net/10668/20107
T2  - Annals of the rheumatic diseases
AB  - Background: Liver alterations, especially nonalcoholic fatty liver disease(NAFLD) are associated with Rheumatoid Arthritis (RA). This abnormalityappears as asymptomatic and can progress to a severe liver damage rapidly.Chronic inflammation, treatment...
LA  - en
PB  - BMJ Group
KW  - Humans
KW  - Methotrexate
KW  - Non-alcoholic Fatty Liver Disease
KW  - Autoimmunity
KW  - Cross-Sectional Studies
KW  - Arthritis, Rheumatoid
KW  - Comorbidity
KW  - Inflammation
TI  - INCREASED LIVER DISEASE RISK IN RHEUMATOID ARTHRITIS IS ASSOCIATED WITH DISEASE ACTIVITY, INFLAMMATORY MARKERS, INSULIN RESISTANCE AND ACPAS. INFLUENCE OF METHOTREXATE
TY  - conference output
VL  - 81
ER  -